Related Experiment Video
Updated: Mar 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Poor metabolic control in primary care].
Niels H Wacher1, Mara Silva1, Leticia Valdez1
1Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, CMN Siglo XXI, IMSS, Ciudad de México, México.
Poor diabetes control persists globally. Key factors include disease progression, poor diet, and insufficient treatment adjustments, necessitating targeted interventions for better patient outcomes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Public Health
Background:
- Persistent poor metabolic control in diabetes patients globally.
- Limited success in achieving therapeutic targets despite available resources.
- Focus on identifying root causes within primary care settings.
Purpose of the Study:
- To identify factors contributing to poor metabolic control in diabetes patients.
- Investigate causes within Family Medicine Clinics of the Instituto Mexicano del Seguro Social in Mexico City.
Main Methods:
- Analysis of 638 patients from a 2000-2006 study.
- Recorded anthropometric data, infections, treatment adherence, prescriptions, diet, exercise, and lab results.
- Statistical analysis including Odds Ratios (OR) and 95% Confidence Intervals (CI).
Main Results:
- Worsening glycemic control (HbA1c < 7%) from 38.9% to 21.4%.
- Decreased LDL cholesterol control (51.9% to 12.2%) and blood pressure control (35.6% to 23.3%).
- Caloric-rich diet (OR: 2.36) and treatment intensification (OR: 2.1) linked to poor control; 90% of undertreated patients lacked intensified therapy.
Conclusions:
- Disease progression, inadequate diet, and lack of treatment intensification are primary drivers of poor metabolic control.
- Intervention programs must address these specific factors for improved diabetes management.
- Infections and non-adherence were not significantly associated with elevated HbA1c in this cohort.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Errors occurring during blood pressure monitoring
Several factors...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes Mellitus: Type 2 and Gestational

